Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.

Biotechnology

Health Care

Universal Cells

Taku Yoshida

Michaela Anderson

David Fine

Chelsea Maguire

Katie Lombardo

Lisa Petek

Noboru Yamaji

The Leadership Team at Universal Cells is responsible for guiding the strategic direction of the company, overseeing research and development efforts, and ensuring the successful commercialization of the company's proprietary stem cell therapies. This team combines executive oversight with scientific expertise to drive innovation, manage key projects, and facilitate collaborations to advance Universal Cells' mission of creating universal donor stem cells.

Leadership Team

Research and Development

Leadership Team

About

Team members

Other teams at Universal Cells

Research and Development

Research and Development